Late Breaking Abstract - FACE: Cluster phenotyping predicting outcomes in a prospective multicenter cohort study of chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV). Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019
FACE: A prospective multicentre observational cohort study in patients with chronic heart failure (CHF) and central sleep apnoea (CSA) treated with adaptive servoventilation (ASV) Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Respiratory function in chronic stroke patients: an observational study. Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions Year: 2021
Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Year: 2015
A randomised controlled trial of cognitive behavioural therapy (CBT) delivered by respiratory nurses to reduce anxiety in chronic obstructive pulmonary disease (COPD). (Trial registration - ISCRCTN55206395) Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016
Incidence, severity, and predictive risk factors of obstructive sleep apnoea(OSA) among south Indian patients, a retrospective observational study in a general respiratory clinic. Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020
Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR) Source: Eur Respir J, 52 (2) 1701927; 10.1183/13993003.01927-2017 Year: 2018
OSACO: an observational study in asthma-COPD overlap syndrome (ACOS) Source: International Congress 2017 – Bronchial asthma management Year: 2017
An integrated care management program (ICMP) for patients with severe COPD; mortality, hazards and causes Source: International Congress 2015 – Best abstracts in chronic care Year: 2015
Indacaterol/glycopyrronium (IND/GLY) reduces the risk of clinically important deterioration (CID) versus open-label tiotropium (Tio) in COPD patients: Post hoc analysis from SHINE and SPARK studies Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study. Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Patients‘ perception of their own influence on asthma (locus of control). Results from an observational study Source: Eur Respir J 2007; 30: Suppl. 51, 147s Year: 2007
A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006
Comparison of diagnostic value of patient health questionnaire 9 (PHQ-9) and Beck depression inventory (BDI) questionnaire for preliminary diagnosing of depression in COPD patients (pts) Source: International Congress 2014 – COPD markers Year: 2014
The effect of pulmonary rehabilitation (PR) on anxiety and depression symptoms in bronchiectasis: a propensity-matched study Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019
The severity of anxiety in COPD patients (pts) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017
COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level Source: Annual Congress 2012 - COPD exacerbation Year: 2012
Late Breaking Abstract - FACE: Prospective multicenter cohort adressing chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV): patient baseline characteristics Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019
Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD Source: International Congress 2015 – Different data in COPD Year: 2015